Format

Send to

Choose Destination
See comment in PubMed Commons below
Nat Biotechnol. 2011 Mar;29(3):245-54. doi: 10.1038/nbt.1791.

Beyond natural antibodies: the power of in vitro display technologies.

Author information

1
Los Alamos National Laboratory, Los Alamos, New Mexico, USA. amb@lanl.gov

Abstract

In vitro display technologies, best exemplified by phage and yeast display, were first described for the selection of antibodies some 20 years ago. Since then, many antibodies have been selected and improved upon using these methods. Although it is not widely recognized, many of the antibodies derived using in vitro display methods have properties that would be extremely difficult, if not impossible, to obtain by immunizing animals. The first antibodies derived using in vitro display methods are now in the clinic, with many more waiting in the wings. Unlike immunization, in vitro display permits the use of defined selection conditions and provides immediate availability of the sequence encoding the antibody. The amenability of in vitro display to high-throughput applications broadens the prospects for their wider use in basic and applied research.

PMID:
21390033
PMCID:
PMC3057417
DOI:
10.1038/nbt.1791
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for Nature Publishing Group Icon for PubMed Central
    Loading ...
    Support Center